Viewing Study NCT04044560


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-31 @ 2:25 PM
Study NCT ID: NCT04044560
Status: TERMINATED
Last Update Posted: 2022-02-21
First Post: 2019-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
Sponsor: University of British Columbia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module